Ribometrix - Crunchbase Company Profile & Funding

Q: Who invested in Ribometrix?

Ribometrix has 10 investors including Illumina Ventures And MP Healthcare Venture Management.

Q: When was the last funding round for Ribometrix?

Ribometrix closed its last funding round on obfuscated from a Venture - Series Unknown round.

Q: How much funding has Ribometrix raised to date?

Ribometrix has raised obfuscated.

Overview

Ribometrix

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Ribometrix

CB Rank

37996

Ribometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases.

Founded

obfuscation

Private

Venture - Series Unknown

Greenville, South Carolina, United States

11-50

www.ribometrix.com/

Biotechnology

Health Care

Life Science

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Seed

OBF

obfuscation

Key People

William Janzen: Vice President, Lead Discovery and Research Operations
Past Role: Chaperone Therapeutics, CEO
Katie Warner: Co-Founder & Vice President, RNA Biology

Details

Legal Name

Ribometrix, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Katie Warner

About the Company

Ribometrix is a platform therapeutics company that discovers small molecule drugs that target functional 3D RNA structures to treat human diseases. Our scientific offices are located in the newly renovated Biolabs Space in Durham, with offices in Chapel Hill and Boston.

Phone Number

(252) 551-1088

Contact Email

inquiries@ribometrix.com

Diversity Spotlight

Women Founded

Predictions & Insights

Growth Insight

See this Growth Insight

Ribometrix is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

RNA-targeted Small Molecule Therapeutics Platform

A platform that uses specialized technologies to identify 3D RNA motifs and design small molecules that bind to these motifs to modulate RNA function and treat diseases.

Direct RNA Targeting

A strategy to identify and drug complex RNA structures to prevent the production of disease-causing proteins.

Research & Development

Ribometrix is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Ribometrix	3	obfuscated obfuscation	Dementia Discovery Fund, Illumina Ventures	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Illumina Ventures	Yes	Venture Round - Ribometrix	—
Illumina Ventures	Yes	Venture Round - Ribometrix	—
Illumina Ventures	Yes	Venture Round - Ribometrix	—
Illumina Ventures	Yes	Venture Round - Ribometrix	—
Illumina Ventures	Yes	Venture Round - Ribometrix	—